Librela
Zoetis
Control of pain associated with osteoarthritis in dogs.
Bedinvetmab is a monoclonal antibody directed at nerve growth factor.
Read the official recordPeptide Science
A clear view of the veterinary regulatory landscape—and why the distinction matters.
Regulated products
Approval or licensure follows controlled development, manufacturing review, labeling, and ongoing safety monitoring. The regulator depends on the product category.
Research and wellness compounds
BPC-157, TB-500, KPV, GHK-Cu, Selank, Semax, Thymosin Alpha-1, MOTS-c, and SS-31 are not FDA-approved for veterinary use. Their evidence varies widely and does not establish safe or effective use in dogs.
These products are included for education. Pawformance Labs does not sell them and is not affiliated with Zoetis.
Zoetis
Control of pain associated with osteoarthritis in dogs.
Bedinvetmab is a monoclonal antibody directed at nerve growth factor.
Read the official recordZoetis
Control of clinical signs associated with atopic dermatitis in dogs.
Lokivetmab is a monoclonal antibody directed at canine interleukin-31. It is USDA-licensed, not FDA-approved.
Read the official recordZoetis
Control of pain associated with osteoarthritis in cats.
Frunevetmab is a feline-specific monoclonal antibody directed at nerve growth factor.
Read the official record